Hope S. Rugo, MD

Professor of Medicine
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
Authored Items
HR+/HER2- Metastatic Breast Cancer: Common Presenting Symptoms
Hope S. Rugo, MD
Videos in Breast Cancer, Video
CDK4/6 Inhibitors vs Chemotherapy for Patients with Metastatic Breast Cancer
Hope S. Rugo, MD
Conference Correspondent  in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Hot Topics at SABCS 2017
Hope S. Rugo, MD
Conference Correspondent  in SABCS 2017 - Breast Cancer, Breast Cancer, Video
HER2+ Breast Cancer and CDK4/6 Inhibitors
Hope S. Rugo, MD
Conference Correspondent  in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Disease Progression with a CDK4/6 Inhibitor plus an Aromatase Inhibitor
Hope S. Rugo, MD
Conference Correspondent  in SABCS 2017 - Breast Cancer, Breast Cancer, Video
What Differentiates Abemaciclib, Ribociclib, and Palbociclib?
Hope S. Rugo, MD
Conference Correspondent  in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Why CDK4/6 Inhibitors Are Effective in HR-Positive Metastatic Breast Cancer
Hope S. Rugo, MD
Conference Correspondent  in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Last modified: December 5, 2017